Credit: n/a
December 22 - Three clinical trial platforms working together to test the effects of full doses of anticoagulants (blood thinners) in COVID-19 patients have paused enrollment for one group of patients. Among critically ill COVID-19 patients requiring intensive care unit (ICU) support, full dose anticoagulation drugs did not improve outcomes. Enrollment continues for moderately ill hospitalized COVID-19 patients in the trials.
As is normal for clinical trials, these trials are overseen by independent boards that routinely review the data and are composed of experts in ethics, biostatistics, clinical trials, and blood clotting disorders. Informed by the deliberations of these oversight boards, all of the trial sites have paused enrollment of the most critically ill hospitalized patients with COVID-19. A potential for harm in this sub-group could not be excluded. Increased bleeding is a known complication of full-dose anticoagulation. The trials are working urgently to u
Winnipeg Free Press
photos by RUTH BONNEVILLE / WINNIPEG FREE PRESS
Maples Collegiate student Brody McQueen has worked on various wall panels intended to spread hopeful, uplifting messages that aren’t ‘toxic positivity.’
It was only fitting the panels on which students were tasked with painting comforting messages in Brody McQueen’s Grade 12 art class this term were customized to be six-feet tall.
It was only fitting the panels on which students were tasked with painting comforting messages in Brody McQueen’s Grade 12 art class this term were customized to be six-feet tall. Be the reason someone feels heard, states the board made by McQueen and his project partner, Shakira Rampersad.
WINNIPEG A new study has found a way to potentially reduce the risk of children developing a peanut allergy. The study, led by researchers from the University of Manitoba as well as McMaster University looked at how a baby s sensitivity to peanuts was affected if the mother was eating peanuts while breastfeeding, and also introducing peanut products to babies before they were a year old. Dr. Meghan Azad, who is an associate professor at the U of M and is also with the Children s Hospital Research Institute of Manitoba, is the lead researcher on this study and said the theory is called the triple exposure hypothesis.
15 Dec 2020
A Chinese researcher that worked for Nationwide Children’s Hospital Research Institute in Ohio pleaded guilty in a U.S. District Court over his role in a scheme to steal American trade secrets on behalf of the Chinese government. Researcher Yu Zhou is just one of many foreign researchers that have been caught attempting to smuggle American research to foreign governments in 2020.
According to a report by the College Fix, a 50-year-old researcher who worked for the Nationwide Children’s Hospital Reserach Institute in Ohio has pled guilty after conspiring to steal trade secrets and sell them to the Chinese government. Yu Zhou reportedly sold cutting-edge American medical research to the Chinese government.
Heads-up! Hangover cure might be here soon
By Shaun Smillie
Share
Finally the millennia-long search for a hangover cure might be over and it doesn’t involve celery sticks or raw eggs.
In fact this cure kills a hangover before it even starts.
A team of Canadian researchers have come up with a device that has the potential to quickly sober up drunks.
And it’s a simple device that uses hyperventilation and the lungs to expel alcohol.
“It s a very basic, low-tech device that could be made anywhere in the world: no electronics, no computers or filters are required.